Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -87.45% is 37% above its 5-year average of -139.31%, near the high end of its 5-year range (-981.49%–-57.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 75.68% above its 12-month average of -359.55%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -87.45%.
RETURN ON EQUITY (ROE)
-87.45%
RETURN ON EQUITY (ROE) AVG TTM
-359.55%
RETURN ON EQUITY (ROE) AVG 3Y
-296.19%
RETURN ON EQUITY (ROE) AVG 5Y
-139.31%
RETURN ON EQUITY (ROE) AVG 10Y
-119.96%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.68%
CURRENT VS 3Y AVG
+70.48%
CURRENT VS 5Y AVG
+37.23%
CURRENT VS 10Y AVG
+27.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-108.16%
vs the sector median at left
Immunic, Inc.
Market Cap
$106.18M
Return on Equity (ROE)
-87.45%
TTM Avg
-359.55%
3Y Avg
-296.19%
5Y Avg
-139.31%
Market Cap
$106.33M
Return on Equity (ROE)
-99.67%
TTM Avg
-40.73%
3Y Avg
98.81%
5Y Avg
13.93%
Market Cap
$107.43M
Return on Equity (ROE)
N/A
TTM Avg
148.53%
3Y Avg
-12.61%
5Y Avg
-408.56%
Market Cap
$108.33M
Return on Equity (ROE)
-93.44%
TTM Avg
-8.16%
3Y Avg
13.24%
5Y Avg
13.24%
Market Cap
$108.23M
Return on Equity (ROE)
-138.73%
TTM Avg
-151.26%
3Y Avg
-114.36%
5Y Avg
-241.91%
Market Cap
$105.93M
Return on Equity (ROE)
-60.82%
TTM Avg
-19.88%
3Y Avg
-19.08%
5Y Avg
-15.27%
Market Cap
$104.00M
Return on Equity (ROE)
-44.29%
TTM Avg
-31.86%
3Y Avg
-53.29%
5Y Avg
-49.85%
Market Cap
$104.21M
Return on Equity (ROE)
-116.28%
TTM Avg
-71.19%
3Y Avg
-41.66%
5Y Avg
-29.50%
Market Cap
$103.68M
Return on Equity (ROE)
-62.61%
TTM Avg
-420.52%
3Y Avg
-378.99%
5Y Avg
-378.99%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunic, Inc. (IMUX) | $106.18M | -87.45% | -359.55% | -296.19% | -139.31% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.33M | -99.67% | -40.73% | 98.81% | 13.93% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.43M | N/A | 148.53% | -12.61% | -408.56% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.33M | -93.44% | -8.16% | 13.24% | 13.24% |
| Vivani Medical, Inc. (VANI)vs › | $108.23M | -138.73% | -151.26% | -114.36% | -241.91% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.93M | -60.82% | -19.88% | -19.08% | -15.27% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | -44.29% | -31.86% | -53.29% | -49.85% |
| Definitive Healthcare Corp. (DH)vs › | $104.21M | -116.28% | -71.19% | -41.66% | -29.50% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | -62.61% | -420.52% | -378.99% | -378.99% |
| Apyx Medical Corporation (APYX)vs › | $109.07M | -80.97% | -121.11% | -93.50% | -70.15% |
ROE
-87.4%
ROA
-70.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -87.45% |
| 2026-03-31 | -68.96% |
| 2025-09-30 | -981.49% |
| 2025-06-30 | -300.30% |
| 2024-12-31 | -545.37% |
| 2024-09-30 | -235.10% |
| 2024-06-30 | -149.91% |
| 2024-03-31 | -117.17% |
| 2023-12-31 | -323.57% |
| 2023-09-30 | -265.49% |
| 2023-06-30 | -183.26% |
| 2023-03-31 | -136.89% |
| 2022-12-31 | -105.91% |
| 2022-09-30 | -78.23% |
| 2022-06-30 | -65.07% |
| 2022-03-31 | -57.42% |
| 2021-12-31 | -73.12% |
| 2021-09-30 | -57.00% |
| 2021-06-30 | -63.39% |
| 2021-03-31 | -50.98% |
| 2020-12-31 | -27.72% |
| 2020-09-30 | -24.90% |
| 2020-06-30 | -45.56% |
| 2020-03-31 | -77.46% |
| 2019-12-31 | -68.73% |
| 2019-09-30 | -57.64% |
| 2019-06-30 | -55.63% |
| 2019-03-31 | -404.24% |
| 2018-12-31 | -333.75% |
| 2018-09-30 | -376.08% |
| 2018-06-30 | -204.66% |
| 2018-03-31 | -144.43% |
| 2017-12-31 | -104.06% |
| 2017-09-30 | -79.29% |
| 2017-06-30 | -63.98% |
| 2017-03-31 | -52.09% |
| 2016-12-31 | -70.10% |
| 2016-09-30 | -57.69% |
| 2016-06-30 | -55.59% |
| 2016-03-31 | -60.03% |
| 2015-12-31 | -63.19% |
| 2015-09-30 | -95.64% |
| 2015-06-30 | -81.19% |
| 2015-03-31 | -61.68% |
| 2014-12-31 | -48.86% |
| 2014-09-30 | -57.04% |
| 2014-06-30 | -42.77% |
| 2013-12-31 | -78.99% |
